Annexon Inc (ANNX)
7.255
+0.16
(+2.33%)
USD |
NASDAQ |
Nov 05, 16:00
7.255
0.00 (0.00%)
After-Hours: 20:00
Annexon Enterprise Value: 380.39M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 380.39M |
| November 01, 2024 | 400.46M |
| October 31, 2024 | 404.69M |
| October 30, 2024 | 427.93M |
| October 29, 2024 | 431.10M |
| October 28, 2024 | 431.10M |
| October 25, 2024 | 413.14M |
| October 24, 2024 | 417.37M |
| October 23, 2024 | 406.80M |
| October 22, 2024 | 431.10M |
| October 21, 2024 | 421.59M |
| October 18, 2024 | 421.59M |
| October 17, 2024 | 437.44M |
| October 16, 2024 | 436.38M |
| October 15, 2024 | 418.42M |
| October 14, 2024 | 414.20M |
| October 11, 2024 | 411.03M |
| October 10, 2024 | 372.99M |
| October 09, 2024 | 365.60M |
| October 08, 2024 | 359.26M |
| October 07, 2024 | 280.02M |
| October 04, 2024 | 295.86M |
| October 03, 2024 | 287.41M |
| October 02, 2024 | 309.60M |
| October 01, 2024 | 276.85M |
| Date | Value |
|---|---|
| September 30, 2024 | 256.77M |
| September 27, 2024 | 280.02M |
| September 26, 2024 | 277.90M |
| September 25, 2024 | 278.96M |
| September 24, 2024 | 296.92M |
| September 23, 2024 | 333.90M |
| September 20, 2024 | 374.05M |
| September 19, 2024 | 373.52M |
| September 18, 2024 | 363.48M |
| September 17, 2024 | 369.82M |
| September 16, 2024 | 387.26M |
| September 13, 2024 | 392.01M |
| September 12, 2024 | 342.35M |
| September 11, 2024 | 284.24M |
| September 10, 2024 | 291.64M |
| September 09, 2024 | 288.47M |
| September 06, 2024 | 238.81M |
| September 05, 2024 | 246.21M |
| September 04, 2024 | 221.91M |
| September 03, 2024 | 202.89M |
| August 30, 2024 | 233.53M |
| August 29, 2024 | 257.83M |
| August 28, 2024 | 258.89M |
| August 27, 2024 | 270.51M |
| August 26, 2024 | 276.85M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-135.12M
Minimum
Mar 30 2022
1.202B
Maximum
Aug 12 2020
243.55M
Average
150.78M
Median
Enterprise Value Benchmarks
| Arbutus Biopharma Corp | 586.71M |
| CEL-SCI Corp | 50.50M |
| AIM ImmunoTech Inc | 8.843M |
| IGC Pharma Inc | 26.81M |
| NovaBay Pharmaceuticals Inc | 3.645M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -29.61M |
| Total Expenses (Quarterly) | 33.58M |
| EPS Diluted (Quarterly) | -0.23 |
| Earnings Yield | -16.82% |